Top Markets
#1 Siren Siren +40.14%
#2 RedStone RedStone +24.77%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +22.65%
#4 Perle Perle +16.73%
#5 Ocean Protocol Ocean Protocol +15.17%
#6 KUB Coin KUB Coin +14.22%
#7 Verus Coin Verus Coin +13.72%
#8 Cysic Cysic +10.99%
#9 Quack AI Quack AI +10.58%
#10 Arowana Arowana +10.51%
Coin of the day
Siren Siren
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Hoth Therapeutics, Inc. Hoth Therapeutics, Inc.

Hoth Therapeutics, Inc.

HOTH
Pozycja w akcjach #32249
Hoth Therapeutics, Inc. engages in the development of new generation therapies... Hoth Therapeutics, Inc. engages in the development of new generation therapies for dermatological disorders. Its product pipeline focuses on potential treatments for indications including atopic dermatitis (also known as eczema), chronic wounds, psoriasis, asthma, and acne. It offers the BioLexa Platform, a drug compound platform for the treatment of eczema. The company was founded by Robbie Knie, Matthew D. Eitner, and James Ahern on May 16, 2017 and is headquartered in New York, NY.
Cena akcji
$0.8013
Ostatnia synchronizacja: 2026-08-05
Kapitalizacja rynkowa
$10.62M
Zmiana (1 dzień)
0.97%
Zmiana (1 rok)
-37.88%
Kraj
US
Handel Hoth Therapeutics, Inc. (HOTH)

Kategoria

Healthcare
Historia stopy dywidendy dla Hoth Therapeutics, Inc. (HOTH)
Stopa dywidendy (TTM) dla Hoth Therapeutics, Inc. (symbol akcji: HOTH) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla Hoth Therapeutics, Inc. (HOTH) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
Za mało danych dla podanych dat.
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji
Firma Stopa dywidendy Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
0.00%
KR